pXR001: EF1a-CasRx-2A-EGFP Citations (40)
Originally described in: Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD Cell. 2018 Mar 8. pii: S0092-8674(18)30207-1. doi: 10.1016/j.cell.2018.02.033. PubMed Journal
Articles Citing pXR001: EF1a-CasRx-2A-EGFP
Showing 1 to 10 of 40 entries
| Articles |
|---|
Articles |
|---|
CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.
Wang L, Bitar M, Lu X, Jacquelin S, Nair S, Sivakumaran H, Hillman KM, Kaufmann S, Ziegman R, Casciello F, Gowda H, Rosenbluh J, Edwards SL, French JD.
Mol Cancer. 2024 May 15;23(1):101. doi: 10.1186/s12943-024-02021-y.
PubMed
Associated Plasmids |
| Autism Spectrum Disorder- and/or Intellectual Disability-Associated Semaphorin-5A Exploits the Mechanism by Which Dock5 Signalosome Molecules Control Cell Shape. Okabe M, Sato T, Takahashi M, Honjo A, Okawa M, Ishida M, Kukimoto-Niino M, Shirouzu M, Miyamoto Y, Yamauchi J. Curr Issues Mol Biol. 2024 Apr 2;46(4):3092-3107. doi: 10.3390/cimb46040194. PubMed |
| Engineering a synthetic gene circuit for high-performance inducible expression in mammalian systems. De Carluccio G, Fusco V, di Bernardo D. Nat Commun. 2024 Apr 17;15(1):3311. doi: 10.1038/s41467-024-47592-y. PubMed |
| SAFB restricts contact domain boundaries associated with L1 chimeric transcription. Hong Y, Bie L, Zhang T, Yan X, Jin G, Chen Z, Wang Y, Li X, Pei G, Zhang Y, Hong Y, Gong L, Li P, Xie W, Zhu Y, Shen X, Liu N. Mol Cell. 2024 May 2;84(9):1637-1650.e10. doi: 10.1016/j.molcel.2024.03.021. Epub 2024 Apr 10. PubMed |
| Programmable RNA 5-methylcytosine (m5C) modification of cellular RNAs by dCasRx conjugated methyltransferase and demethylase. Zhang T, Zhao F, Li J, Sun X, Zhang X, Wang H, Fan P, Lai L, Li Z, Sui T. Nucleic Acids Res. 2024 Apr 12;52(6):2776-2791. doi: 10.1093/nar/gkae110. PubMed |
| Knockdown of Kmt2d leads to growth impairment by activating the Akt/beta-catenin signaling pathway. Shangguan H, Huang X, Lin J, Chen R. G3 (Bethesda). 2024 Mar 6;14(3):jkad298. doi: 10.1093/g3journal/jkad298. PubMed |
| CRISPR-based resistance to grapevine virus A. Spencer KP, Burger JT, Campa M. Front Plant Sci. 2023 Dec 4;14:1296251. doi: 10.3389/fpls.2023.1296251. eCollection 2023. PubMed |
| AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice. Keng CT, Yogarajah T, Lee RCH, Muhammad IBH, Chia BS, Vasandani SR, Lim DS, Guo K, Wong YH, Mok CK, Chu JJH, Chew WL. EBioMedicine. 2023 Jul;93:104682. doi: 10.1016/j.ebiom.2023.104682. Epub 2023 Jun 28. PubMed |
| Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing. Zhang X, Wang X, Lv J, Huang H, Wang J, Zhuo M, Tan Z, Huang G, Liu J, Liu Y, Li M, Lin Q, Li L, Ma S, Huang T, Lin Y, Zhao X, Rong Z. Genome Biol. 2023 Jun 23;24(1):145. doi: 10.1186/s13059-023-02992-z. PubMed |
| Mitigating a TDP-43 proteinopathy using RNA-targeting CRISPR effector proteins. Zeballos C MA, Moore HJ, Powell JE, Smith TJ, Zhang S, Gaj T. bioRxiv. 2023 Apr 8:2023.04.07.536072. doi: 10.1101/2023.04.07.536072. Preprint. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.